GANX
Gain Therapeutics Inc
NASDAQ: GANX · HEALTHCARE · BIOTECHNOLOGY
$1.76
-4.86% today
Updated 2026-04-29
Market cap
$83.70M
P/E ratio
—
P/S ratio
255.50x
EPS (TTM)
$-0.61
Dividend yield
—
52W range
$1 – $4
Volume
0.7M
Gain Therapeutics Inc (GANX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $811634.00 | $660286.00 | $9.60M | $38.99M | $24.10M | $18.61M | $12.12M |
| Cash & equivalents | $400694.00 | $303320.00 | $7.49M | $36.88M | $7.31M | $11.79M | $10.39M |
| Current assets | $494638.00 | $398047.00 | $8.99M | $37.72M | $21.09M | $17.78M | $11.60M |
| Total liabilities | $1.76M | $1.11M | $3.40M | $4.17M | $5.22M | $6.03M | $4.78M |
| Current liabilities | $530786.00 | $879052.00 | $2.11M | $2.55M | $4.13M | $4.95M | $3.91M |
| Long-term debt | — | — | $715656.00 | $590468.00 | $495258.00 | $449053.00 | $328327.00 |
| Shareholder equity | $-950908.00 | $-449856.00 | $6.20M | $34.82M | $18.88M | $12.58M | $7.34M |
| Retained earnings | $-1.26M | $-3.46M | $-7.03M | $-20.93M | $-38.52M | $-60.78M | $-81.19M |
| Accounts receivable | $41794.00 | $44915.00 | $8548.00 | $195448.00 | $103877.00 | $242577.00 | $765763.00 |
| Inventory | — | $31478.00 | $1.36M | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |